NCT02655263View on ClinicalTrials.gov

Substrate Metabolism, Growth Hormone Signaling (GH), and Insulin Sensitivity During GH and Ketone Bodies Infusion

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions

Healthy

Interventions

DRUG

Somatropin

Somatropin infusion (Genotropin®)

OTHER

Ketone bodies

ketone bodies infusion

Trial Locations (1)

8000

Aarhus University Hospital, Aarhus

All Listed Sponsors

lead

University of Aarhus

OTHER

NCT02655263 - Substrate Metabolism, Growth Hormone Signaling (GH), and Insulin Sensitivity During GH and Ketone Bodies Infusion | Biotech Hunter | Biotech Hunter